|Videos|April 9, 2013
Episode 24 - Accountable Care Organizations
Advertisement
Episodes in this series
During this segment, David Calabrese, RPh, MHP, and Kenneth L. Schaecher, MD, FACP, CPC, discuss accountable care organizations (ACOs) and their impact on patient care.
Dr Schaecher explains that although ACOs are constructed to benefit healthcare professionals and patients, he fears that an ACO model of care may cause clinicians to under-utilize expensive drug
therapies.
Dr Schaecher hopes that healthcare professionals will continue to make the best choice for their patients and ignore the financial pressures that often play a role in the treatment decision-making process.
Advertisement
Related to this article
The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
In states that covered obesity-labeled GLP-1 RAs, total GLP-1 RA use rose less than obesity-labeled use alone, suggesting possible substitution.
HR 1 brings Medicaid work requirements and narrower immigrant eligibility by January 2027, and CBO projects 10 million more uninsured by 2034.
CMS ends ACA subsidies for 189,000 enrollees with duplicate Medicare, Medicaid, or CHIP coverage or listed as deceased, with a 30-day dispute window.
MedHaul’s platform streamlines nonemergency medical transportation, boosting on-time oncology visits, reducing costs, and helping patients reach critical care across underserved regions.
CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
Advertisement
Advertisement